Agressive Lymphomas. (c2019)
- Record Type:
- Book
- Title:
- Agressive Lymphomas. (c2019)
- Main Title:
- Agressive Lymphomas
- Further Information:
- Note: Georg Lenz, Gilles Salles, editors.
- Other Names:
- Lenz, Georg
Salles, Gilles - Contents:
- Intro; Contents; Introduction; Part I: Epidemiology, Pathology and Molecular Pathogenesis; 1: Epidemiology of Aggressive Lymphomas; 1.1 Introduction and Scope; 1.2 Descriptive Epidemiology; 1.2.1 Frequency; 1.2.2 Incidence; 1.2.2.1 DLBCL; 1.2.2.2 BL; 1.2.2.3 PTCL; 1.2.3 Survival; 1.2.3.1 DLBCL; 1.2.3.2 BL; 1.2.3.3 PTCL; 1.2.4 Other Measures; 1.2.4.1 Mortality Rate; 1.2.4.2 Event-Free Status at 24 Months (EFS24); 1.3 Analytic Epidemiology of Aggressive Lymphomas; 1.3.1 General Considerations; 1.3.2 Specific Considerations; 1.3.3 DLBCL; 1.3.3.1 Family History and Genetics 1.3.3.2 Immune Biomarkers1.3.3.3 Infectious Agents; 1.3.3.4 Medical History; 1.3.3.5 Hormonal and Reproductive Factors; 1.3.3.6 Occupations and Environmental Factors; 1.3.3.7 Hair Dye; 1.3.3.8 Anthropometrics and Physical Activity; 1.3.3.9 Smoking and Alcohol Consumption; 1.3.3.10 Diet; 1.3.3.11 Sun Exposure; 1.3.4 Burkitt Lymphoma; 1.3.4.1 Endemic BL; 1.3.4.2 Immunodeficiency- Associated BL; 1.3.4.3 Sporadic BL; 1.3.5 PTCL; 1.3.5.1 Family History and Genetics; 1.3.5.2 Infections; 1.3.5.3 Medical History; 1.3.5.4 Occupations and Environmental Factors 1.3.5.5 Anthropometrics1.3.5.6 Smoking and Alcohol Use; 1.3.5.7 Sun Exposure; 1.3.6 Cross-Subtype Patterns; 1.4 Conclusions and Future Directions; References; 2: Pathology and Molecular Pathogenesis of DLBCL and Related Entities; 2.1 Introduction; 2.2 Diffuse Large B-Cell Lymphoma, NOS; 2.2.1 Pathology; 2.2.2 Immunophenotype; 2.2.3 Cell of Origin and GeneIntro; Contents; Introduction; Part I: Epidemiology, Pathology and Molecular Pathogenesis; 1: Epidemiology of Aggressive Lymphomas; 1.1 Introduction and Scope; 1.2 Descriptive Epidemiology; 1.2.1 Frequency; 1.2.2 Incidence; 1.2.2.1 DLBCL; 1.2.2.2 BL; 1.2.2.3 PTCL; 1.2.3 Survival; 1.2.3.1 DLBCL; 1.2.3.2 BL; 1.2.3.3 PTCL; 1.2.4 Other Measures; 1.2.4.1 Mortality Rate; 1.2.4.2 Event-Free Status at 24 Months (EFS24); 1.3 Analytic Epidemiology of Aggressive Lymphomas; 1.3.1 General Considerations; 1.3.2 Specific Considerations; 1.3.3 DLBCL; 1.3.3.1 Family History and Genetics 1.3.3.2 Immune Biomarkers1.3.3.3 Infectious Agents; 1.3.3.4 Medical History; 1.3.3.5 Hormonal and Reproductive Factors; 1.3.3.6 Occupations and Environmental Factors; 1.3.3.7 Hair Dye; 1.3.3.8 Anthropometrics and Physical Activity; 1.3.3.9 Smoking and Alcohol Consumption; 1.3.3.10 Diet; 1.3.3.11 Sun Exposure; 1.3.4 Burkitt Lymphoma; 1.3.4.1 Endemic BL; 1.3.4.2 Immunodeficiency- Associated BL; 1.3.4.3 Sporadic BL; 1.3.5 PTCL; 1.3.5.1 Family History and Genetics; 1.3.5.2 Infections; 1.3.5.3 Medical History; 1.3.5.4 Occupations and Environmental Factors 1.3.5.5 Anthropometrics1.3.5.6 Smoking and Alcohol Use; 1.3.5.7 Sun Exposure; 1.3.6 Cross-Subtype Patterns; 1.4 Conclusions and Future Directions; References; 2: Pathology and Molecular Pathogenesis of DLBCL and Related Entities; 2.1 Introduction; 2.2 Diffuse Large B-Cell Lymphoma, NOS; 2.2.1 Pathology; 2.2.2 Immunophenotype; 2.2.3 Cell of Origin and Gene Expression Profiling; 2.2.4 Molecular Pathogenesis; 2.2.4.1 Genetic Lesions Found in Both GCB-DLBCL and ABC-DLBCL; 2.2.4.2 Genetic Lesions Associated with GCB-DLBCL; 2.2.4.3 Genetic Lesions Associated with ABC-DLBCL 2.3 High-Grade B-Cell Lymphomas2.3.1 High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements (HGBL-DH); 2.3.2 High-Grade B-Cell Lymphoma Not Otherwise Specified (HGBL-NOS); 2.4 Other Lymphomas of Large B Cells and Special Subtypes/Variants; 2.4.1 T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; 2.4.2 Intravascular Large B-Cell Lymphoma; 2.4.3 Plasmablastic Lymphoma; 2.4.4 ALK-Positive Large B-Cell Lymphoma; 2.4.5 Primary Mediastinal (Thymic) Large B-Cell Lymphoma 2.4.6 B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma2.4.7 Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type; 2.4.8 Primary Central Nervous System Lymphoma; 2.4.9 Epstein-Barr Virus (EBV)-Positive Diffuse Large B-Cell Lymphoma NOS; 2.4.10 Primary Effusion Lymphoma; 2.4.11 Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation; 2.4.12 Lymphomatoid Granulomatosis; 2.4.13 HHV8-Positive Diffuse Large B-Cell Lymphoma, NOS; 2.5 Concluding Remarks; References … (more)
- Publisher Details:
- Cham : Springer
- Publication Date:
- 2019
- Copyright Date:
- 2019
- Extent:
- 1 online resource (357 p.)
- Subjects:
- 616.99/4
Lymphomas
Electronic books - Languages:
- English
- ISBNs:
- 9783030003623
3030003620 - Related ISBNs:
- 9783030003616
3030003612 - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.381897
- Ingest File:
- 02_364.xml